[(3S,5R,8R,9S,10S,13R,14S,16S,17R)-14-hydroxy-3-[(2R,4S,5S,6S)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] acetate

Oleandrin; LC-ESI-ITFT; MS2; CE: 15%; R=15000; [M+H]+

Oleandrin; LC-ESI-ITFT; MS2; CE: 25%; R=15000; [M+H]+

Oleandrin; LC-ESI-ITFT; MS2; CE: 35%; R=15000; [M+H]+

Oleandrin; LC-ESI-ITFT; MS2; CE: 45%; R=15000; [M+H]+

Oleandrin; LC-ESI-Q; MS; NEG; 30 V

Oleandrin; LC-ESI-Q; MS; POS; 15 V

Oleandrin; LC-ESI-Q; MS; POS; 30 V

Oleandrin; LC-ESI-Q; MS; POS; 45 V

Oleandrin; LC-ESI-Q; MS; POS; 60 V, 90 V